Population Pharmacokinetics of Dolutegravir in HIV-Infected Pediatric Subjects

被引：0
|
作者：
Singh, Rajendra P. [1 ]
Edwards, Alena Yin [2 ]
Ruel, Theodore [3 ]
Wiznia, Andrew [4 ]
Acosta, Edward [5 ]
Hazra, Rohan [6 ]
Buchanan, Ann M. [7 ]
机构：
[1] GlaxoSmithKline, CPMS, Philadelphia, PA USA
[2] ICON Plc Ireland, Dublin, Ireland
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] Univ Alabama Birmingham, Birmingham, AL USA
[6] NICHD, NIH, Bethesda, MD USA
[7] ViiV Healthcare, Res Triangle Pk, NC USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
W-64
引用
收藏
页码：S114 / S114
页数：1
相关论文
共 50 条
  • [1] Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients
    Zhang, Jianping
    Hayes, Siobhan
    Sadler, Brian M.
    Minto, Ilisse
    Brandt, Julie
    Piscitelli, Steve
    Min, Sherene
    Song, Ivy H.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (03) : 502 - 514
  • [2] Population Pharmacokinetics of Dapsone in HIV-Infected Children
    Mark Mirochnick
    Ellen Cooper
    Jing Xu
    Jane Lindsey
    Edmund Capparelli
    Ken McIntosh
    James McNamara
    Lynne M Mofenson
    David Jacobus
    Pediatric Research, 1999, 45 (7) : 168 - 168
  • [3] Population pharmacokinetics of dapsone in HIV-infected children
    Mirochnick, M
    Cooper, E
    Xu, J
    Lindsey, J
    Capparelli, E
    McIntosh, K
    McNamara, J
    Mofenson, LM
    Jacobus, D
    PEDIATRIC RESEARCH, 1999, 45 (04) : 168A - 168A
  • [4] Ocular involvement in pediatric HIV-infected population
    Muccioli, C
    Nakanami, CR
    Belfort, R
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 4157 - 4157
  • [5] Population pharmacokinetics of nevirapine in Thai HIV-infected patients
    Wattanakul, Thanaporn
    Avihingsanon, Anchalee
    Manosuthi, Weerawat
    Punyawudho, Baralee
    ANTIVIRAL THERAPY, 2014, 19 (07) : 651 - 660
  • [6] Lopinavir population pharmacokinetics on HIV-infected pregnant women
    Bouillon-Pichault, M.
    Treluyer, J. M.
    Rey, E.
    Pons, G.
    Jullien, V.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 23 - 23
  • [7] Pharmacokinetics and safety of saquinavir/ritonavir and omeprazole in HIV-infected subjects
    Singh, K.
    Dickinson, L.
    Chaikan, A.
    Back, D.
    Fletcher, C.
    Pozniak, A.
    Moyle, G.
    Nelson, M.
    Gazzard, B.
    Herath, D.
    Boffito, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (06) : 867 - 872
  • [8] Dolutegravir approved for HIV-infected adults, children
    Thompson, Cheryl A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (18) : 1557 - 1557
  • [9] Population pharmacokinetics of 25-hydroxycholecalciferol in HIV-infected adults
    Foissac, F.
    Treluyer, J. M.
    Rostane, H.
    Urien, S.
    Viard, J. P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 117 - 117
  • [10] Population pharmacokinetics of boosted saquinavir regimens in HIV-infected individuals
    Dickinson, Laura
    Boffito, Marta
    Back, David
    Khoo, Saye
    Pozniak, Anton
    Byakika-Kibwika, Pauline
    Merry, Concepta
    Autar, Reshma Saskia
    Burger, David
    Aarons, Leon
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (06) : 995 - 996
12345